Author:
Kong Qing-Zhou,Peng Cheng,Li Zhen,Tian Bao-Ling,Li Yue-Yue,Chen Fei-Xue,Zuo Xiu-Li,Li Yan-Qing
Abstract
Goals: To explore factors associated with inadequate gastric preparation for MCE.Background: Factors associated with inadequate gastric preparation for magnetically controlled capsule endoscopy (MCE) remains unclear.Study: Data of patients who underwent MCE from June 2021 to July 2022 were prospectively collected. The gastric cleanliness score (GCS) of the six stomach regions (gastric cardia, fundus, body, angulus, antrum, and pylorus) was recorded. Patients with GCS score ≥18 were defined as the adequate preparation. Factors related to inadequate gastric preparation were analyzed using a logistic regression model with estimated odds ratios (OR).Results: The mean GCS score of 211 patients was 17.01 ± 2.82. In the multivariable analysis, proton pump inhibitor (PPI) use (OR 3.57; 95% CI 1.69–7.95; p < 0.01) and premedication time after administering simethicone <30 min (OR 2.86; 95% CI 1.10–7.39; p = 0.03) were independent risk factors for inadequate gastric preparation. Comparing the gastric cleanliness of different locations, the median GCS of the lower stomach [10.00, IQR (9.50, 11.00)] was significantly higher than that of the upper stomach [7.00, IQR (6.00, 8.00)] (p <0.001).Conclusion: PPI use and inadequate premedication time (<30 min) may reduce the quality of gastric preparation for MCE. The type, dose, duration of medication, and discontinuation time of PPIs was well worth further exploration. Appropriate control of the type and time of premedication may be the key to improving overall gastric cleanliness.
Subject
Pharmacology (medical),Pharmacology
Reference31 articles.
1. Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test;Anjiki;Digestion,2005
2. Use of gascon and pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: A prospective, randomized, controlled, blinded trial;Bhandari;Scand. J. Gastroenterol.,2010
3. Capsule Endoscopy Collaborative Group of Chinese Society of D, et al. Chinese guideline on magnetically controlled capsule gastroscopy (2021, Shanghai);Chin. J. Dig. Endosc.,2021
4. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy;Chang;J. Gastroenterol. Hepatol.,2014
5. The China expert consensus of clinical practice for magnetically controlled capsule gastroscopy(2017, Shanghai);Zhonghua Nei Ke Za Zhi,2017